先锋手术宣布新生物学间间隔者的成功人类植入

先锋外科技术公司,是创新医疗设备的领导者,今天宣布了其新的生物学间间隔剂的成功植入。Nanoss(TM) - 颈笼是通过机械强大的纳米晶型羟基磷灰石(HA)加工的,其设计为充当骨骼。这些手术是在北京和中国苏州的医院对使用Nanoss(TM) - 颈植入物,骨移植物材料和前宫颈板进行标准宫颈融合手术的患者进行的。

Dr. Hansen Yuan, Professor of Orthopaedic and Neurological Surgery, State University of New York Upstate Medical University, Syracuse, NY performed the surgeries with Chinese surgeons and says, "The nanOss-Cervical cage was handled and implanted similarly to PEEK (poly-ether-ether-ketone) cages, and was used in conjunction with routine rigid fixation. The benefit of nanOss technology to the patient is it is a safe, natural substance and is biocompatible."

先锋的Nanoss子宫颈笼旨在通过同时保持减压并作为传统的刚性固定来促进脊柱融合程序。

Pioneer's CEO and Chairman of the Board, Dr. Matthew N. Songer says, "The hydroxyapatite nanOss-Cervical design is the frontier of the new generation of biologic implants that will replace the foreign materials that are currently used to reconstruct the spine."

In less than a year from acquiring the nanOss technology, Pioneer's development teams have created the nanOss-Cervical cage for fusion procedures. Strength properties of materials made of nanOss technology are twice as strong as PEEK cages yet, being biologic, behave as if it were bone.

告诉我们你的想法

您是否有评论,更新或想添加到此新闻故事中的任何内容?

留下您的反馈
Your comment type
提交